Moleculin Biotech MBRX Balance Sheet (2015-2026)

NASDAQ MBRX
$0.59 +0.02 (+3.51%)
At close: Aug 20, 2026 · 4:00 PM EDT
Balance Sheet Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Assets
Current Assets
Cash & Equivalents (Quarter)
79.50M75.20M70.90M66.10M58.00M50.40M43.15M37.27M32.20M24.60M23.55M16.82M10.85M9.40M4.28M7.72M7.56M6.70M8.88M7.26M
Cash & Current Investments (Quarter)
79.50M75.20M70.90M66.10M58.00M50.40M43.15M37.27M32.20M24.60M23.55M16.82M10.85M9.40M4.28M7.72M7.56M6.70M8.88M7.26M
Receivables - Net (Quarter)
0.02M0.01M
Receivables - Other (Quarter)
0.02M0.02M0.03M0.00M0.00M0.01M0.10M0.01M0.02M0.00M0.00M0.00M0.01M0.00M
Receivables (Quarter)
0.02M0.01M
Prepaid Assets (Quarter)
2.33M1.89M0.59M1.16M3.32M0.94M2.45M2.02M3.21M3.02M2.72M2.13M2.89M2.20M0.55M0.29M1.07M0.79M0.51M1.46M
Current Assets (Quarter)
81.84M77.07M72.50M67.26M61.32M53.49M45.60M39.29M35.38M27.60M26.27M18.96M13.73M11.61M5.19M9.34M9.08M7.88M9.69M8.72M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
0.40M0.35M0.34M0.31M0.34M0.31M0.28M0.24M0.23M0.23M0.27M0.24M0.22M0.19M0.16M0.13M0.10M0.08M0.08M0.06M
Intangibles (Quarter)
11.10M11.10M11.10M11.10M11.10M
Goodwill & Intangibles (Quarter)
11.15M11.15M11.15M11.15M11.15M11.15M11.15M11.15M11.15M11.15M11.15M11.15M11.15M11.15M11.15M11.15M11.15M11.15M11.15M11.15M
Other Non-Current Assets (Quarter)
0.90M0.90M0.90M0.90M
Non-Current Assets (Quarter)
11.70M11.63M11.59M11.54M11.93M11.88M11.83M11.77M11.73M11.92M11.94M11.89M11.84M11.79M11.73M11.67M12.52M12.47M12.44M12.36M
Assets (Quarter)
93.53M88.70M84.09M78.80M73.25M65.37M57.42M51.06M47.12M39.52M38.22M30.84M25.57M23.39M16.93M21.01M21.59M20.35M22.13M21.09M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
1.50M1.39M1.36M2.22M3.18M3.57M2.10M1.94M4.14M2.01M2.50M2.10M2.83M2.55M2.03M2.71M3.72M2.12M3.51M4.34M
Notes Payables (Quarter)
Payables (Quarter)
1.50M1.39M1.36M2.22M3.18M3.57M2.10M1.94M4.14M2.01M2.50M2.10M2.83M2.55M2.03M2.71M3.72M2.12M3.51M4.34M
Accumulated Expenses (Quarter)
0.11M2.27M2.26M0.87M0.14M1.34M0.75M3.09M2.42M1.88M4.32M1.09M2.91M3.04M1.82M4.19M1.68M3.57M1.82M4.98M
Other Accumulated Expenses (Quarter)
Short term Debt (Quarter)
0.11M0.12M0.10M0.11M0.09M
Current Leases (Quarter)
0.10M0.08M0.10M0.11M0.12M
Total Current Liabilities (Quarter)
3.35M3.66M3.62M4.83M5.86M6.36M4.82M5.03M6.55M3.89M6.82M5.41M5.75M5.59M5.36M6.90M7.91M5.68M6.85M9.31M
Non-Current Liabilities
Non-Current Deffered Revenue (Quarter)
Operating Leases (Quarter)
0.09M0.07M0.06M0.05M0.39M0.36M0.34M0.31M0.29M0.50M0.47M0.45M0.42M0.39M0.36M0.33M0.29M0.26M0.22M0.15M
Other Non-Current Liabilities (Quarter)
5.39M3.71M1.41M1.25M0.65M0.23M0.08M0.04M0.00M0.00M4.86M3.40M1.70M9.93M16.97M41.33M0.04M0.04M
Total Non-Current Liabilities (Quarter)
3.44M3.73M3.69M4.88M6.25M6.73M5.15M5.34M6.84M4.38M7.29M5.86M6.17M5.98M5.72M7.22M8.21M5.94M7.08M9.46M
Total Liabilities (Quarter)
8.83M7.44M5.10M6.14M6.90M6.96M5.23M5.38M6.85M4.38M12.14M9.26M7.87M15.91M5.72M7.22M25.18M47.27M7.12M9.50M
Shareholder's Equity
Total Debt (Quarter)
0.11M0.12M0.10M0.11M0.09M
Common Equity (Quarter)
84.70M81.26M78.99M72.67M66.36M58.42M52.19M45.68M40.27M35.14M30.93M24.99M19.41M17.41M11.21M13.79M-3.58M-26.92M15.01M11.59M
Liabilities and Shareholders Equity (Quarter)
93.53M88.70M84.09M78.80M73.25M65.37M57.42M51.06M47.12M39.52M38.22M30.84M25.57M23.39M16.93M21.01M21.59M20.35M22.13M21.09M
Retained Earnings (Quarter)
-65.60M-69.98M-72.81M-79.68M-86.45M-95.10M-101.83M-109.75M-115.73M-121.33M-131.60M-136.57M-140.89M-151.50M-172.44M-178.35M-196.16M-221.56M0.01M-226.50M
Treasury Shares (Quarter)
0.22M0.04M0.09M0.00M0.01M